Zheng Hua Ren
Direktor/Vorstandsmitglied bei Hangzhou Shangjian Biotechnology Co., Ltd.
Profil
Zheng Hua Ren has worked as a Director at Hangzhou Shangjian Biotechnology Co., Ltd.
and as a Partner at ADDOR Capital Management Co. Ltd.
Aktive Positionen von Zheng Hua Ren
| Unternehmen | Position | Beginn |
|---|---|---|
ADDOR Capital Management Co. Ltd.
 ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Private Equity Investor | - |
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ADDOR Capital Management Co. Ltd.
ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Finance |
Hangzhou Shangjian Biotechnology Co., Ltd.
Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Health Technology |